Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
Patients who experience severe symptoms of heart failure and repeated hospitalizations for exacerbations may benefit from positive inotropic drug infusion therapy such as dobutamine or milrinone. This article provides an overview of inotropic drug delivery in the home including current controversies and best practices to ensure safe home care policies and practice.
Gorski
Lisa A
LA
Covenant Home Health & Hospice, Milwaukee, WI, USA. ml_gorski@msn.com
D002316:Cardiotonic Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D004280:Dobutamine / Q000008:administration & dosage; D004298:Dopamine / Q000008:administration & dosage; D005260:Female; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing; D006439:Hemodynamics / Q000502:physiology; D018718:Home Infusion Therapy / Q000191:economics / Q000379:methods* / Q000451:nursing; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D020105:Milrinone / Q000008:administration & dosage; D008991:Monitoring, Physiologic; D018579:Patient Selection; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D002316:Cardiotonic Agents; D004280:Dobutamine; D020105:Milrinone; D004298:Dopamine